Integra Lifesciences Holdings (IART) Short-term Investments (2012 - 2026)

Integra Lifesciences Holdings (IART) has 6 years of Short-term Investments data on file, last reported at $28.7 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 16.1% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $28.7 million (down 16.1% YoY), and the FY2025 full-year result was $28.7 million, up 5.49% from the prior year.
• Short-term Investments steadied at $28.7 million in Q1 2026, from $28.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $81.7 million in Q2 2024 to a low of $27.2 million in Q4 2024.
• A 4-year average of $43.8 million and a median of $34.9 million in 2025 frame the typical range for Short-term Investments.
• Peak annual rise in Short-term Investments reached 5.49% in 2025, while the deepest fall reached 56.31% in 2025.
• Tracing IART's Short-term Investments over 4 years: stood at $32.7 million in 2023, then fell by 16.82% to $27.2 million in 2024, then climbed by 5.49% to $28.7 million in 2025, then changed by 0.0% to $28.7 million in 2026.
• Business Quant data shows IART's Short-term Investments at $28.7 million in Q1 2026, $28.7 million in Q4 2025, and $35.7 million in Q3 2025.